Compare AstraZeneca plc (AZN) vs Financial Select Sector SPDR Fund (XLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Financial Select Sector SPDR Fund — how do they compare? AstraZeneca plc trades at $157.98 (market cap $245.16B), while Financial Select Sector SPDR Fund trades at $58.29. The key difference: AstraZeneca plc pays a 2.02% dividend while Financial Select Sector SPDR Fund pays none, and Financial Select Sector SPDR Fund is trading nearer its 52-week high, AstraZeneca plc nearer its low. Which is the better fit depends on your goals.
| AZN | XLF | |
|---|---|---|
Market Cap | $245.16B | — |
Sector | Health | — |
52-Week High | $209.48 | $58.01 |
52-Week Low | $147.06 | $47.80 |
Enterprise Value | $272.43B | — |
Dividend Yield | 2.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AstraZeneca (AZN) trades at $157.24, down 0.95% on the day, amid bearish technical signals and merger speculation. The company shows strong fundamentals with revenue growth from $44.4B in 2022 to $58.7B in 2025 and net income margin improving to 17.4%. Recent earnings beats and a 47.5% analyst buy rating contrast with technical indicators showing selling pressure and legal investigations creating near-term uncertainty.
AZN presents a mixed outlook with strong pharmaceutical fundamentals offset by technical weakness and merger-related volatility. The investment case hinges on continued earnings growth and strategic execution, while risks include integration challenges from potential M&A and ongoing legal scrutiny. Wall Street remains predominantly bullish despite recent price pressure.
XLF trades at $57.91, up 0.17% with a bullish technical outlook as it crosses above its 200-day moving average of $52.72. The ETF recently hit record highs amid sector rotation into financials, with strong inflows and positive sentiment around AI financing opportunities. Moving averages signal strong bullish momentum while oscillators remain neutral.
The financial sector ETF benefits from Wall Street's expanding role in AI infrastructure funding and strong bank earnings. Key risks include valuation concerns and market volatility. Technical support sits at $57 with resistance at $58. The outlook remains positive given sector momentum and institutional interest.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Financial Select Sector SPDR Fund
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →
